Surgical Technology International 35th Edition
New Online Studies
Online First - May 2019
1 year Institutional Subscription
both electronic and print versions
Clinical Outcomes of Patients with Severe Aortic Valve Stenosis Treated with Portico,
Transcatheter Aortic Valve System
Alberto Pozzoli MD, Maurizio Taramasso MD PhD, Mizuki Miura MD PhD, Gökhan Gülmez MD,
Shu-I Lin MD, Mara Gavazzoni MD, Francesco Maisano MD, Heart Valve Clinic, University Hospital
of Zurich, University of Zurich, Zurich, Switzerland, Phillip Haager MD, Cardiology Department,
Hans Rickli MD, Cardiology Department, Kantonsspital St. Gallen, St. Gallen, Switzerland
1119
The Portico™ transcatheter aortic valve implantation (TAVI) system (Abbott Vascular, Santa Clara, CA, USA) was specifically designed to reduce some of the limitations associated with first-generation TAVI devices. Most of the currently available clinical evidence was obtained from randomized studies that compared TAVI to aortic valve replacement using first-generation transcatheter heart valve devices. The aim of this review is to describe the characteristics of the repositionable and retrievable Portico™ system and the technique of implantation, as well as to provide an overview of the most recent outcomes in the literature, along with our institutional experience.
Order Digital ePrint:
PDF Format - $77.00
1 Year Subscription
including this article:
Online PDF - $399.00
